INVO Bioscience Inc (INVO)
0.9249
-0.01
(-0.66%)
USD |
NASDAQ |
May 03, 16:00
0.92
0.00 (0.00%)
After-Hours: 20:00
INVO Bioscience Free Cash Flow (Quarterly): -0.7899M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.7899M |
| September 30, 2023 | -1.356M |
| June 30, 2023 | -1.906M |
| March 31, 2023 | -1.148M |
| December 31, 2022 | -1.004M |
| September 30, 2022 | -1.651M |
| June 30, 2022 | -1.876M |
| March 31, 2022 | -2.085M |
| December 31, 2021 | -1.183M |
| September 30, 2021 | -2.357M |
| June 30, 2021 | -1.180M |
| March 31, 2021 | -1.764M |
| December 31, 2020 | -1.851M |
| September 30, 2020 | -0.9687M |
| June 30, 2020 | -1.156M |
| March 31, 2020 | -0.8886M |
| December 31, 2019 | -0.7711M |
| September 30, 2019 | -0.6185M |
| June 30, 2019 | -0.3943M |
| March 31, 2019 | 3.040M |
| December 31, 2018 | -0.2863M |
| September 30, 2018 | -0.1171M |
| June 30, 2018 | -0.2122M |
| March 31, 2018 | -0.0374M |
| December 31, 2017 | -0.0195M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.0274M |
| June 30, 2017 | -0.0216M |
| March 31, 2017 | -0.1128M |
| December 31, 2016 | -0.1062M |
| September 30, 2016 | -0.065M |
| June 30, 2016 | -0.0997M |
| March 31, 2016 | -0.0687M |
| December 31, 2015 | -0.1026M |
| September 30, 2015 | -0.0251M |
| June 30, 2015 | -0.0048M |
| March 31, 2015 | -0.0192M |
| December 31, 2011 | 0.0463M |
| September 30, 2011 | -0.0583M |
| June 30, 2011 | -0.0426M |
| March 31, 2011 | -0.0631M |
| December 31, 2010 | 0.115M |
| September 30, 2010 | -0.1407M |
| June 30, 2010 | -0.108M |
| March 31, 2010 | -0.1824M |
| December 31, 2009 | -0.2534M |
| September 30, 2009 | -0.3247M |
| June 30, 2009 | -0.0677M |
| March 31, 2009 | -0.281M |
| December 31, 2008 | -1.124M |
| September 30, 2008 | 0.1498M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-2.357M
Minimum
Sep 2021
-0.3943M
Maximum
Jun 2019
-1.313M
Average
-1.180M
Median
Jun 2021
Free Cash Flow (Quarterly) Benchmarks
| Abbott Laboratories | 2.283B |
| Perspective Therapeutics Inc | -9.097M |
| Xtant Medical Holdings Inc | -1.278M |
| Asensus Surgical Inc | -13.45M |
| Catheter Precision Inc | -1.907M |